Related Experiment Video
Updated: Jun 27, 2026
12:17
The 4-vessel Sampling Approach to Integrative Studies of Human Placental Physiology In Vivo
Published on: August 2, 2017
10.8K
NGAL for Preeclampsia: How Sure are We?
Sachin Gupta1, Deeksha S Tomar1
1Department of Critical Care Medicine, Narayana Superspeciality Hospital, Gurugram, Haryana, India.
Summary
Neutrophil gelatinase-associated lipocalin (NGAL) shows promise as a biomarker for preeclampsia, but more research is needed to confirm its reliability. Current evidence is insufficient to definitively establish NGAL as a standard diagnostic tool for this pregnancy complication.
Area of Science:
- Obstetrics and Gynecology
- Nephrology
- Biomarker Discovery
Background:
- Preeclampsia is a serious pregnancy complication characterized by high blood pressure.
- Early and accurate diagnosis of preeclampsia is crucial for maternal and fetal outcomes.
- Neutrophil gelatinase-associated lipocalin (NGAL) has emerged as a potential biomarker for various kidney-related conditions.
Discussion:
- This review critically evaluates the current evidence on the utility of NGAL in diagnosing and managing preeclampsia.
- Studies investigating NGAL levels in preeclampsia have yielded mixed results, highlighting variability in methodologies and patient populations.
- The role of NGAL as a standalone or adjunctive biomarker for preeclampsia requires further investigation.
Key Insights:
- NGAL's potential as a non-invasive biomarker for preeclampsia is supported by some studies.
- However, inconsistencies in NGAL detection methods and lack of standardization limit its current clinical application.
- More robust, large-scale studies are essential to validate NGAL's diagnostic accuracy and prognostic value in preeclampsia.
Outlook:
- Future research should focus on standardizing NGAL assays and conducting prospective studies to confirm its clinical utility.
- Investigating NGAL's role in differentiating preeclampsia from other hypertensive disorders of pregnancy is warranted.
- Establishing reliable biomarkers like NGAL could significantly improve the management of preeclampsia.
Related Concept Videos
01:33Hormonal Regulation
The renin-aldosterone system is an endocrine system which guides the renal absorption of water and electrolytes, thus managing blood pressure and osmoregulation. Activation of the system begins in the kidneys with a small cluster of cells adjacent to the afferent and efferent blood vessels of the renal corpuscle. As the nephrons are filtering blood, juxtaglomerular cells monitor blood pressure. If they detect a decrease in pressure, they release the hormone renin into the bloodstream.
01:19Mitral Valve Prolapse III: Nursing Management
The nursing management of Mitral Valve Prolapse, or MVP, centers around patient education, symptom monitoring, and lifestyle modifications.Patient Education on MVP Diagnosis and Heredity: Nurses should provide comprehensive education about MVP, a condition where the mitral valve does not close appropriately during heartbeats. This education often includes the condition's pathophysiology, symptoms, and potential complications, like arrhythmias or mitral regurgitation. Though not fully...
01:26Nephrotic Syndrome II : Assessment and Medical Management
IntroductionNephrotic syndrome is a kidney disorder marked by excessive protein loss in the urine, leading to various systemic complications. This condition often results from damage to the glomeruli—the kidney's filtering units—causing proteinuria, low blood protein levels, and fluid retention. Understanding the assessment, diagnosis, and management of nephrotic syndrome is essential for effective treatment and prevention of further kidney damage.AssessmentPatient History: Document any history...